ir.immunicum.com ir.immunicum.com

ir.immunicum.com

Immunicum AB - Investerare

Företrädesemission - läs mer. Ladda ner prospekt. Klinisk Fas I/II-studie (RCC). Välkommen till Immunicums investerarsidor! Här presenteras information som kan vara av intresse för Bolagets aktieägare, analytiker och andra intressenter. För ytterligare information eller frågor kontakta VD Jamal El-Mosleh. Jamal El-Mosleh, VD. Tel: 031- 41 50 53. E-post: jamal.el-mosleh@immunicum.com. Visa alla meddelanden ». 13 augusti, 2015. Magnus Persson föreslås till ny styrelseledamot i Immunicum. 5 augusti, 2015.

http://ir.immunicum.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR IR.IMMUNICUM.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

March

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.9 out of 5 with 9 reviews
5 star
8
4 star
1
3 star
0
2 star
0
1 star
0

Hey there! Start your review of ir.immunicum.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.9 seconds

CONTACTS AT IR.IMMUNICUM.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Immunicum AB - Investerare | ir.immunicum.com Reviews
<META>
DESCRIPTION
Företrädesemission - läs mer. Ladda ner prospekt. Klinisk Fas I/II-studie (RCC). Välkommen till Immunicums investerarsidor! Här presenteras information som kan vara av intresse för Bolagets aktieägare, analytiker och andra intressenter. För ytterligare information eller frågor kontakta VD Jamal El-Mosleh. Jamal El-Mosleh, VD. Tel: 031- 41 50 53. E-post: jamal.el-mosleh@immunicum.com. Visa alla meddelanden ». 13 augusti, 2015. Magnus Persson föreslås till ny styrelseledamot i Immunicum. 5 augusti, 2015.
<META>
KEYWORDS
1 choose language
2 immunicum
3 meny
4 om immunicum
5 sub menu
6 strategi
7 historik
8 organisation
9 ledning
10 styrelse
CONTENT
Page content here
KEYWORDS ON
PAGE
choose language,immunicum,meny,om immunicum,sub menu,strategi,historik,organisation,ledning,styrelse,vetenskapligt råd,teknologi,plattformar,combig plattformen,intuvax,subcuvax,cd70 plattformen,immateriella rättigheter,vetenskapliga publikationer,pipeline
POWERED BY
ASP.NET
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Immunicum AB - Investerare | ir.immunicum.com Reviews

https://ir.immunicum.com

Företrädesemission - läs mer. Ladda ner prospekt. Klinisk Fas I/II-studie (RCC). Välkommen till Immunicums investerarsidor! Här presenteras information som kan vara av intresse för Bolagets aktieägare, analytiker och andra intressenter. För ytterligare information eller frågor kontakta VD Jamal El-Mosleh. Jamal El-Mosleh, VD. Tel: 031- 41 50 53. E-post: jamal.el-mosleh@immunicum.com. Visa alla meddelanden ». 13 augusti, 2015. Magnus Persson föreslås till ny styrelseledamot i Immunicum. 5 augusti, 2015.

OTHER SITES

ir.imde.ac.cn ir.imde.ac.cn

中国科学院水利部成都山地灾害与环境研究所机构知识库(IMHE OpenIR): Home

Have you forgotten your password? Journal . [694]. Journal . [753]. 20世纪80年代末以来中国土地利用变化的基本. [期刊论文, 2015-08]. 龙门山地区的动物资源 [期刊论文, 2015-08]. 高分辨率地震勘探 [期刊论文, 2015-08]. 四川棉花生产布局问题 [期刊论文, 2015-08]. 卧龙自然保护区日臻完善 [期刊论文, 2015-08]. 对美国环境保护的几点考察 [期刊论文, 2015-08]. 四川贡嘎山地区的泥石流及其防治 [期刊论文, 2015-08]. 四川乐山五通石麟镇原始桫椤林科学考察报告 [期刊论文, 2015-08]. 计算机处理摄谱法光谱分析数据 [期刊论文, 2015-08]. 对川西九龙地区农、林、牧生产布局的初步探. [期刊论文, 2015-08]. Choose a community to browse its collections. Journal of Mountain Science. 2 Ecological and E. 5 Effects of human.

ir.immersion.com ir.immersion.com

Investor | Immersion Corporation

Skip to main navigation. Where can I experience haptics? San Jose, California, 95134, USA. T: 1 408.467.1900. F: 1 408.467.1901. Invest in the Future. IR News and Events. Mar 08, 2018. Immersion Files Additional Lawsuits Against Samsung in U.S. and China. Mar 07, 2018. Feb 22, 2018 at 5:00 PM EST. Q4 2017 Immersion Corporation Earnings Conference Call. Nov 2, 2017 at 5:00 PM EDT. Q3 2017 Immersion Corporation Earnings Conference Call. View all Stock Information. San Jose, California, 95134.

ir.immomo.com ir.immomo.com

Momo - Investors - Investor Home

Stock Quote and Chart. Momo Second Quarter 2015 Earnings Conference Call. 160;at 9:00 pm ET. Momo Second Quarter 2015 Earnings Conference Call. Wednesday, August 19, 2015 . 9:00 pm ET  . Click here for webcast. Click here to add this event to your calendar. Momo connects people in a personal and lively way. Momo has become an integral part of the daily lives of many people in China, where the increasing proliferation of smartphones and netw. Momo First Quarter 2015 Earnings Conference Call. 160; 0.41.

ir.immudyne.com ir.immudyne.com

ImmuDyne, Inc. (IMMD)

ImmuDyne, Inc. (OTCQB: IMMD) is a biotech Company focused on R&D and commercialization of a proprietary yeast-derived beta-glucan, Beta-1/3,1/6-glucan, for serious unmet needs including epidermal, anti-infective, anti-cancer, and anti-inflammatory markets. Beta-glucan has been published in over 6000 scientific papers and is an immune-modulator that binds to and activates Natural Killer (NK), dendritic (DC), and other immune cells, as shown in Figure 1 (below). Figure 1. Beta-Glucan Mechanism of Action.

ir.immunedesign.com ir.immunedesign.com

Investor Relations | Immune Design

Harnessing the Immune System to Fight Disease. Infectious Diseases & Allergy. Annual Reports and Proxies. Immune Design is a clinical stage immunotherapy company employing next-generation. Aug 12, 2015. Immune Design Reports Second Quarter 2015 Financial Results. Aug 12, 2015. Immune Design Announces Phase 2 Cancer Immunotherapy Trial Collaboration. View all news releases ». Aug 12, 2015 at 1:30 PM PT. Immune Design Second Quarter 2015 Financial Results. Jun 3, 2015 at 2:00 PM ET. Day High: 17.39.

ir.immunicum.com ir.immunicum.com

Immunicum AB - Investerare

Företrädesemission - läs mer. Ladda ner prospekt. Klinisk Fas I/II-studie (RCC). Välkommen till Immunicums investerarsidor! Här presenteras information som kan vara av intresse för Bolagets aktieägare, analytiker och andra intressenter. För ytterligare information eller frågor kontakta VD Jamal El-Mosleh. Jamal El-Mosleh, VD. Tel: 031- 41 50 53. E-post: jamal.el-mosleh@immunicum.com. Visa alla meddelanden ». 13 augusti, 2015. Magnus Persson föreslås till ny styrelseledamot i Immunicum. 5 augusti, 2015.

ir.impaccompanies.com ir.impaccompanies.com

Investor Relations

Join our email list Sign Up. Follow us on LinkedIn. Your browser does not support iframes. Stay Connected with Impac Companies. Contact Impac Mortgage Corp. (NMLS #128231), for purchase and refi, including Jumbo, Conventional, FHA/VA/USDA, 203k Home Renovation and Reverse Mortgage programs. An agency-direct lender, Impac Mortgage Corp. Wholesale offers a full range of conventional, jumbo, and AltQM loan programs. Innovative thinking, strength of service, personal commitment. As of August 7, 2015 -. Impac...

ir.imperial.com ir.imperial.com

Investor Relations - Imperial Holdings, Inc.

Imperial Finance and Trading. Call Toll Free: 1-888-364-6775. Our Team of Leaders. Annual Reports and Proxies. We are a specialty finance company providing customized liquidity solutions to owners of illiquid financial assets. Imperial purchases and sells life insurance policies issued by insurance companies generally rated "A " or better by Standard and Poor's or "A" or better by am Best Company. As part of its core philosophy Imperial is focused on:. Annual Shareholders Meeting Presentation.

ir.imperialindustries.com ir.imperialindustries.com

imperialindustries.com

ir.imr.ac.cn ir.imr.ac.cn

中国科学院金属研究所机构知识库(IMR OpenIR): Home

Phosphate modified carbon nanotubes for oxida. Electrochemical stability of graphene cathode. Environmentally Assisted Fatigue Evaluation M. Tunable and enhanced luminescence of Ba2-xCax. Applications of porous carbon materials in th. Microstructure Characteristics and Mechanical. Tribological behaviors of turbofan seal coupl. Microwave-Absorption Properties of Three Kind. Theoretical Study on the Relationship Between. Microstructural changes and their effect on t. Total of browse: 4627245.

ir.imshealth.com ir.imshealth.com

IMS Health Incorporated - Corporate Profile

Pharmaceutical: R&D - Clinical. Medical Device and Diagnostics. Presence in Healthcare Growth Markets. IMS Institute for Healthcare Informatics. Electronic Medical Record (EMR) Vendors. Payer: Commercial and Public. Disease and Treatment Insights. Specialty and Oncology Care. Pricing and Market Access. Payer and Provider Performance. Nexxus Commercial Application Suite. BI and Mobility Solutions. Payer and Provider Performance. Lifecycle and Portfolio Management. New Member Risk Profiling. August 7, 2015.